deltatrials
Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07118592

Genetic Architecture of Natriuretic Peptides and Blood Pressure Response

Sponsor: University of Alabama at Birmingham

Updated 3 times since 2025 Last updated: Mar 6, 2026 Started: Sep 1, 2026 Primary completion: Jun 1, 2030 Completion: Dec 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiometabolic Diseases and Hypertension (HTN) and is currently actively recruiting participants. University of Alabama at Birmingham leads this study, which shows 3 recorded versions since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshotNot Yet Recruiting~Oct 2025 – ~Mar 2026 · 5 months · monthly snapshotNot Yet Recruiting~Mar 2026 – present · 4 months · monthly snapshotNot Yet Recruiting

Change History

3 versions recorded
  1. Mar 2026 — Present [monthly]

    Not Yet Recruiting NA

  2. Oct 2025 — Mar 2026 [monthly]

    Not Yet Recruiting NA

  3. Sep 2025 — Oct 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Alabama at Birmingham
Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations